[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100508502":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":13,"centralContacts":18,"locations":27,"responsibleParty":47,"collaborators":7,"id":49,"slug":50,"hasResults":51,"nctId":52,"briefTitle":53,"officialTitle":53,"acronym":54,"eligibilityCriteria":55,"healthyVolunteers":51,"sex":56,"minAge":57,"maxAge":7,"enrollmentInfo":58,"targetDuration":61,"studyType":62,"phases":7,"briefSummary":63,"conditions":64,"keywords":70,"overallStatus":30,"whyStopped":7,"lastUpdateSubmitDate":71,"lastUpdatePostDateStruct":72,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":80},{"fullName":5,"class":6},"Exoneural Network AB","INDUSTRY",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"DEVICE","EXOPULSE Mollii Suit and EXOPULSE Suit","The registry is designed to demonstrate the impact of EXOPULSE Mollii Suit or EXOPULSE Suit on muscle relaxation, muscle activation, local blood circulation and\u002For chronic pain relief. The subjects included use the suit for 60 minutes every other day, unless other is specified by the Investigator, in their home environment for up to a maximum of 2 consecutive weeks. Qualitative and quantitative measures will be collected at baseline (T0), after 60 minutes stimulation (T1), after 2 weeks of home use (T2) and during two additional phone calls 1-3 days after the first stimulation session (T1,5) as well as 4 weeks after the first stimulation session (T3).",[14],{"name":15,"affiliation":16,"role":17},"Milana Mileusnic, PhD","Otto Bock Healthcare Products GmbH","PRINCIPAL_INVESTIGATOR",[19,23],{"name":15,"role":20,"phone":21,"phoneExt":7,"email":22},"CONTACT","+43 6648415079","milana.mileusnic@ottobock.com",{"name":24,"role":20,"phone":25,"phoneExt":7,"email":26},"Sanna Dünesius, MSc","+46 706243064","sanna.dunesius@ottobock.com",[28],{"facility":29,"status":30,"city":31,"state":32,"zip":33,"country":34,"countryCode":35,"cosmosGeoPoint":36,"geoPoint":41,"contacts":42},"Ottobock Care Sverige","RECRUITING","Bergshamra","Stockholm County","170 73","Sweden","SE",{"type":37,"coordinates":38},"Point",[39,40],18.03427,59.38083,{"lat":40,"lon":39},[43],{"name":44,"role":20,"phone":7,"phoneExt":45,"email":46},"Ines Cunha","+46 764926303","ines.cunha@ottobockcare.se",{"type":48,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100508502","the-exopulse-study---a-database-for-routine-follow-up-of-clinical-outcomes-100508502",false,"NCT05901259","The EXOPULSE Study - a Database for Routine Follow-up of Clinical Outcomes","EXOREG","Inclusion Criteria:\n\n* Diagnosed with CP, MS, stroke, fibromyalgia or other neurologic disorder that may cause such type of symptoms.\n* Diagnosed \\>6 months prior to inclusion in case of MS or stroke as well as \\>1 month prior to inclusion in the case of fibromyalgia.\n* Give written informed consent\n* Cognitively able to understand and follow verbal and\u002For written instructions\n* A minimum age of 2 years\n\nExclusion Criteria:\n\n* Any of the contraindications listed in the instructions for use of the EXOPULSE Mollii Suit or EXOPULSE Suit\n* Being introduced to any new medication affecting the neuromuscular activity during the study period\n* Using botulinum toxin \\\u003C3 month before or during the study period\n* Subjects \\\u003C100 cm and \\\u003C13 kg\n* Subjects \\>205 cm and \\>115 kg","ALL","2 Years",{"count":59,"type":60},200,"ESTIMATED","4 Weeks","OBSERVATIONAL","The objective is to explore the potential short and long-term impact of the EXOPULSE Mollii Suit and EXOPULSE Suit on subjects with CP, MS, stroke, fibromyalgia or other neurologic disorders which may cause such types of symptoms, and to identify high responders among the sub-categories of the diagnoses. The primary endpoint will be improvements in the Berg\u002FPediatric Balance Scale (BBS\u002FPBS) as a measurement of balance and risk of falls.",[65,66,67,68,69],"Cerebral Palsy","Multiple Sclerosis","Stroke","Neurologic Disorder","Fibromyalgia",[54],"2026-02-26",{"date":73,"type":74},"2026-02-27","ACTUAL",{"date":76,"type":74},"2026-02-18",{"date":78,"type":60},"2027-12-31",{"name":5,"class":6},1]